Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

46.5K
Overview
46.5K
Cancer Vaccines01:30

Cancer Vaccines

568
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
568
Development of Immunocompetence01:22

Development of Immunocompetence

516
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
516
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

511
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coprological and Molecular Analyses of Ruminant Farms in Québec, Canada, Show a Variable Efficacy of Ivermectin Against Gastro-Intestinal Nematodes.

Pathogens (Basel, Switzerland)·2025
Same author

In Silico Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (M<sup>pro</sup>).

Pathogens (Basel, Switzerland)·2024
Same author

Design, infectability, and transcriptomic analysis of transregionally differentiated and scalable lung organoids derived from adult bronchial cells.

bioRxiv : the preprint server for biology·2024
Same author

N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life Cycle.

Antimicrobial agents and chemotherapy·2023
Same author

Evaluation of Inhibitory Activity In Silico of In-House Thiomorpholine Compounds between the ACE2 Receptor and S1 Subunit of SARS-CoV-2 Spike.

Pathogens (Basel, Switzerland)·2021
Same author

New Biomarkers of Innate and Adaptive Immunity in Infectious Diseases.

Journal of immunology research·2018
Same journal

Correction: Bulatov et al. Camelpox Virus in Western Kazakhstan: Assessment of the Role of Local Fauna as Reservoirs of Infection. <i>Viruses</i> 2024, <i>16</i>, 1626.

Viruses·2026
Same journal

Correction: Franco et al. Whole Blood Volume-Based Absolute Quantification of HTLV-1 Proviral Load: A Comparative Method Evaluation Study. <i>Viruses</i> 2026, <i>18</i>, 580.

Viruses·2026
Same journal

Correction: Medkour et al. Adenovirus Infections in African Humans and Wild Non-Human Primates: Great Diversity and Cross-Species Transmission. <i>Viruses</i> 2020, <i>12</i>, 657.

Viruses·2026
Same journal

Burden of Malaria and Dengue Across Global, Asian, and Chinese Populations Based on GBD 2021 Data: A Quantitative Assessment of Importation Risks to China.

Viruses·2026
Same journal

First Report of <i>Orthonairovirus songlingense</i> in <i>Haemaphysalis concinna</i> Ticks from Russia.

Viruses·2026
Same journal

Epidemiological and Virological Characteristics of H9N2 Avian Influenza Virus in Jiangsu Province, China, 2024.

Viruses·2026
See all related articles

Related Experiment Video

Updated: Oct 18, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K

AMDV Vaccine: Challenges and Perspectives.

Nathan M Markarian1, Levon Abrahamyan2

  • 1Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada.

Viruses
|September 28, 2021
PubMed
Summary
This summary is machine-generated.

Aleutian mink disease virus (AMDV) causes significant losses in the mink industry. This review examines past vaccine development and control strategies for Aleutian disease (AD) to guide future prevention efforts.

Keywords:
AMDVAleutian diseaseAleutian mink disease virusmink parvovirusvaccine

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.4K

Related Experiment Videos

Last Updated: Oct 18, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.4K

Area of Science:

  • Veterinary Virology
  • Animal Disease Epidemiology

Background:

  • Aleutian mink disease virus (AMDV) is a globally prevalent pathogen causing significant economic losses in the mink industry.
  • AMDV infection, leading to Aleutian disease (AD), is characterized by plasmacytosis and hyperglobulinemia, with current control relying on manual serological testing.
  • The virus's persistent nature has hindered eradication efforts, making effective control strategies crucial for wildlife and industry protection.

Purpose of the Study:

  • To review previous attempts at developing AMDV vaccines for mink.
  • To summarize existing preventative measures against Aleutian disease (AD).
  • To provide insights for future research on effective AMDV immunization strategies.

Main Methods:

  • Literature review of scientific publications on AMDV vaccine development.
  • Analysis of studies detailing immunization trials in mink.
  • Compilation of data on various control and prevention strategies for Aleutian disease.

Main Results:

  • Multiple research efforts have aimed to develop AMDV vaccines, with varying reported success in protecting mink.
  • Despite numerous attempts, no commercially available vaccines currently exist for AMDV.
  • Current control methods are limited, and the virus continues to spread.

Conclusions:

  • The development of an effective AMDV vaccine is critical for controlling Aleutian disease.
  • Further research into AMDV immunization is essential to protect the mink industry and wildlife.
  • A comprehensive understanding of past efforts is necessary to design successful future preventative tools.